Loading...
HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer
BACKGROUND: Tamoxifen resistance remains a significant clinical challenge for the therapy of ER-positive breast cancer. It has been reported that the upregulation of transcription factor SOX9 in ER(+) recurrent cancer is sufficient for tamoxifen resistance. However, the mechanisms underlying the reg...
Na minha lista:
| Udgivet i: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6964674/ https://ncbi.nlm.nih.gov/pubmed/31690832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0625-0 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|